Cellectis Sa Stock Market Value
| CLLS Stock | USD 3.65 0.24 6.17% |
| Symbol | Cellectis |
Is there potential for Biotechnology market expansion? Will Cellectis introduce new products? Factors like these will boost the valuation of Cellectis. Projected growth potential of Cellectis fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Cellectis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.33) | Revenue Per Share | Quarterly Revenue Growth 1.059 | Return On Assets | Return On Equity |
The market value of Cellectis SA is measured differently than its book value, which is the value of Cellectis that is recorded on the company's balance sheet. Investors also form their own opinion of Cellectis' value that differs from its market value or its book value, called intrinsic value, which is Cellectis' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Cellectis' market value can be influenced by many factors that don't directly affect Cellectis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Cellectis' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cellectis should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Cellectis' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cellectis 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cellectis' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cellectis.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Cellectis on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Cellectis SA or generate 0.0% return on investment in Cellectis over 90 days. Cellectis is related to or competes with Alto Neuroscience, AC Immune, Aldeyra, Amarin PLC, Alpha Tau, Larimar Therapeutics, and Silence Therapeutics. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cell... More
Cellectis Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cellectis' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cellectis SA upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.74 | |||
| Information Ratio | 0.0594 | |||
| Maximum Drawdown | 29.31 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 9.24 |
Cellectis Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cellectis' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cellectis' standard deviation. In reality, there are many statistical measures that can use Cellectis historical prices to predict the future Cellectis' volatility.| Risk Adjusted Performance | 0.0704 | |||
| Jensen Alpha | 0.3382 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | 0.0644 | |||
| Treynor Ratio | 0.6463 |
Cellectis February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0704 | |||
| Market Risk Adjusted Performance | 0.6563 | |||
| Mean Deviation | 3.84 | |||
| Semi Deviation | 4.49 | |||
| Downside Deviation | 4.74 | |||
| Coefficient Of Variation | 1291.27 | |||
| Standard Deviation | 5.14 | |||
| Variance | 26.39 | |||
| Information Ratio | 0.0594 | |||
| Jensen Alpha | 0.3382 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | 0.0644 | |||
| Treynor Ratio | 0.6463 | |||
| Maximum Drawdown | 29.31 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 9.24 | |||
| Downside Variance | 22.46 | |||
| Semi Variance | 20.13 | |||
| Expected Short fall | (4.34) | |||
| Skewness | 0.0584 | |||
| Kurtosis | 1.12 |
Cellectis SA Backtested Returns
Currently, Cellectis SA is unstable. Cellectis SA secures Sharpe Ratio (or Efficiency) of 0.0324, which signifies that the company had a 0.0324 % return per unit of risk over the last 3 months. We have found twenty-six technical indicators for Cellectis SA, which you can use to evaluate the volatility of the firm. Please confirm Cellectis' Mean Deviation of 3.84, risk adjusted performance of 0.0704, and Downside Deviation of 4.74 to double-check if the risk estimate we provide is consistent with the expected return of 0.17%. Cellectis has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.6, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cellectis' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cellectis is expected to be smaller as well. Cellectis SA right now shows a risk of 5.14%. Please confirm Cellectis SA sortino ratio, as well as the relationship between the downside variance and rate of daily change , to decide if Cellectis SA will be following its price patterns.
Auto-correlation | -0.22 |
Weak reverse predictability
Cellectis SA has weak reverse predictability. Overlapping area represents the amount of predictability between Cellectis time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cellectis SA price movement. The serial correlation of -0.22 indicates that over 22.0% of current Cellectis price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.22 | |
| Spearman Rank Test | -0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 0.16 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cellectis Stock Analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.